<DOC>
	<DOCNO>NCT00403975</DOCNO>
	<brief_summary>The purpose trial ass effectiveness safety 2 % diquafosol tetrasodium ophthalmic solution versus placebo follow 6 week treatment subject mild moderate dry eye disease .</brief_summary>
	<brief_title>Study Diquafosol Tetrasodium Ophthalmic Solution Subjects With Dry Eye Disease</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>best correct visual acuity eye least +0.7 sixmonth document history dry eye disease least mild severity 1 5 dry eye symptom corneal fluorescein stain great equal 3 less equal 6 ( 15 ) permanent conjunctival goblet cell loss scar condition ongoing contact lens wear current topical ophthalmic medication use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>